Basic Information | Post buying leads | Suppliers | Cas Database |
Name |
Fentiapril |
EINECS | N/A |
CAS No. | 80830-42-8 | Density | 1.451g/cm3 |
PSA | 141.94000 | LogP | 1.67720 |
Solubility | N/A | Melting Point |
147°C (rough estimate) |
Formula | C13H15 N O4 S2 | Boiling Point | 553.7°C at 760 mmHg |
Molecular Weight | 313.398 | Flash Point | 288.7°C |
Transport Information | N/A | Appearance | N/A |
Safety | Risk Codes | N/A | |
Molecular Structure | Hazard Symbols | N/A | |
Synonyms |
4-Thiazolidinecarboxylicacid, 2-(2-hydroxyphenyl)-3-(3-mercapto-1-oxopropyl)-, (2R-cis)-; Fentiapril;Rentiapril; SA 446 |
Article Data | 4 |
IUPAC Name: (2R,4R)-2-(2-Hydroxyphenyl)-3-(3-sulfanylpropanoyl)-1,3-thiazolidine-4-carboxylic acid
Synonyms of Fentiapril (CAS NO.80830-42-8) : (2R,4R)-2-(o-Hydroxyphenyl)-3-(3-mercaptopropionyl)-4-thiazolidinecarboxylic acid ; Prescrin ; Rentiapril ; Rentiaprilum ; 4-Thiazolidinecarboxylic acid, 2-(2-hydroxyphenyl)-3-(3-mercapto-1-oxopropyl)-, (2R-cis)-
InChI: InChI=1/C13H15NO4S2/c15-10-4-2-1-3-8(10)12-14(11(16)5-6-19)9(7-20-12)13(17)18/h1-4,9,12,15,19H,5-7H2,(H,17,18)/t9-,12+/m0/s1
CAS NO:80830-42-8
Molecular Formula:C13H15NO4S2
Molecular Weight :313.3925
Molecular Structure :
Index of Refraction: 1.66
Surface Tension: 70.1 dyne/cm
Density: 1.451 g/cm3
Flash Point: 288.7 °C
Enthalpy of Vaporization: 87.82 kJ/mol
Boiling Point: 553.7 °C at 760 mmHg
Vapour Pressure: 4.29E-13 mmHg at 25°C
Organism | Test Type | Route | Reported Dose (Normalized Dose) | Effect | Source |
---|---|---|---|---|---|
dog | LD50 | intravenous | 200mg/kg (200mg/kg) | BEHAVIORAL: MUSCLE WEAKNESS BEHAVIORAL: ATAXIA LUNGS, THORAX, OR RESPIRATION: CYANOSIS | Oyo Yakuri. Pharmacometrics. Vol. 31, Pg. 235, 1986. |
mouse | LD50 | intraperitoneal | 1gm/kg (1000mg/kg) | BEHAVIORAL: MUSCLE WEAKNESS BEHAVIORAL: ATAXIA LUNGS, THORAX, OR RESPIRATION: CYANOSIS | Oyo Yakuri. Pharmacometrics. Vol. 31, Pg. 235, 1986. |
mouse | LD50 | intravenous | 946mg/kg (946mg/kg) | BEHAVIORAL: MUSCLE WEAKNESS LUNGS, THORAX, OR RESPIRATION: CYANOSIS BEHAVIORAL: ATAXIA | Oyo Yakuri. Pharmacometrics. Vol. 31, Pg. 235, 1986. |
mouse | LD50 | oral | 8050mg/kg (8050mg/kg) | BEHAVIORAL: MUSCLE WEAKNESS BEHAVIORAL: ATAXIA LUNGS, THORAX, OR RESPIRATION: CYANOSIS | Oyo Yakuri. Pharmacometrics. Vol. 31, Pg. 235, 1986. |
mouse | LD50 | subcutaneous | 2213mg/kg (2213mg/kg) | BEHAVIORAL: MUSCLE WEAKNESS LUNGS, THORAX, OR RESPIRATION: CYANOSIS BEHAVIORAL: ATAXIA | Oyo Yakuri. Pharmacometrics. Vol. 31, Pg. 235, 1986. |
rat | LD50 | intraperitoneal | 921mg/kg (921mg/kg) | BEHAVIORAL: MUSCLE WEAKNESS BEHAVIORAL: ATAXIA LUNGS, THORAX, OR RESPIRATION: CYANOSIS | Oyo Yakuri. Pharmacometrics. Vol. 31, Pg. 235, 1986. |
rat | LD50 | intravenous | 884mg/kg (884mg/kg) | BEHAVIORAL: MUSCLE WEAKNESS BEHAVIORAL: ATAXIA LUNGS, THORAX, OR RESPIRATION: CYANOSIS | Oyo Yakuri. Pharmacometrics. Vol. 31, Pg. 235, 1986. |
rat | LD50 | oral | 8290mg/kg (8290mg/kg) | BEHAVIORAL: MUSCLE WEAKNESS BEHAVIORAL: ATAXIA LUNGS, THORAX, OR RESPIRATION: CYANOSIS | Oyo Yakuri. Pharmacometrics. Vol. 31, Pg. 235, 1986. |
rat | LD50 | subcutaneous | 1369mg/kg (1369mg/kg) | BEHAVIORAL: MUSCLE WEAKNESS BEHAVIORAL: ATAXIA LUNGS, THORAX, OR RESPIRATION: CYANOSIS | Oyo Yakuri. Pharmacometrics. Vol. 31, Pg. 235, 1986. |